Cross-Sectional and Longitudinal Assessment of Behavior in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.

20-item behavioral assessment Apraxia of speech Behavioral dysfunction Longitudinal assessment Progressive agrammatic aphasia

Journal

Dementia and geriatric cognitive disorders
ISSN: 1421-9824
Titre abrégé: Dement Geriatr Cogn Disord
Pays: Switzerland
ID NLM: 9705200

Informations de publication

Date de publication:
2022
Historique:
received: 22 11 2021
accepted: 26 02 2022
pubmed: 9 5 2022
medline: 7 6 2022
entrez: 8 5 2022
Statut: ppublish

Résumé

Progressive agrammatic aphasia (PAA) can be associated with abnormal behaviors; however, it is unknown whether behaviors occur and/or are different in patients with primary progressive apraxia of speech (PPAOS). We aimed to compare baseline and longitudinal behavioral symptomatology between PPAOS, patients with PAA, and patients with both apraxia of speech and PAA (AOS-PAA). We recruited 89 patients for this study, 40 with PPAOS, 11 with PAA, and 38 with AOS-PAA. Behavioral disturbances were evaluated using the frontal behavior inventory (FBI) which was also split into negative behaviors and disinhibition, and the 20-item behavioral assessment scale (20-BAS). Data analysis was performed using linear regression and linear mixed models. Of the 89 patients in the study, 54% were women and the mean age at onset was 68 years. All patients, regardless of diagnosis, endorsed at least one symptom on the FBI at baseline, most frequently verbal apraxia (100%), logopenia (95.6%), irritability (55.9%), and apathy (42.6%). On the 20-BAS, 47.6% of the patients endorsed at least one symptom, most commonly "crying more easily" (19.5%) and personality change (18.3%). PPAOS was the least behaviorally affected group, with differences between PPAOS and AOS-PAA mainly driven by negative behaviors as opposed to disinhibition for PPAOS and PAA. The behavioral metrics showed average sensitivity and specificity to distinguish between groups. Behavioral disturbances worsened over time although rate of behavioral change across groups was similar. Behavioral disturbances are more common and severe in patients with agrammatic aphasia with or without AOS compared to patients with isolated apraxia of speech.

Identifiants

pubmed: 35526526
pii: 000524474
doi: 10.1159/000524474
pmc: PMC9190067
mid: NIHMS1801194
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-202

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC010367
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC012519
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC014942
Pays : United States

Informations de copyright

© 2022 S. Karger AG, Basel.

Références

J Neurol Sci. 2010 Jun 15;293(1-2):35-8
pubmed: 20400120
Neurology. 2014 May 13;82(19):1729-35
pubmed: 24727315
Brain. 1962 Dec;85:665-78
pubmed: 14026018
Arch Clin Neuropsychol. 1999 Aug;14(6):481-7
pubmed: 14590575
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
J Commun Disord. 2014 Sep-Oct;51:43-50
pubmed: 25092638
J Geriatr Psychiatry Neurol. 2013 Dec;26(4):221-9
pubmed: 23904354
Brain. 2014 Oct;137(Pt 10):2783-95
pubmed: 25113789
J Neurol. 2015 Sep;262(9):2064-72
pubmed: 26076744
Brain. 2012 May;135(Pt 5):1522-36
pubmed: 22382356
J Neurol Sci. 2020 Sep 15;416:117007
pubmed: 32623141
Brain Lang. 2018 Sep;184:54-65
pubmed: 29980072
Neurol Clin Pract. 2021 Jun;11(3):249-255
pubmed: 34484892
Can J Neurol Sci. 1997 Feb;24(1):29-36
pubmed: 9043744
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neuroimage Clin. 2018 Mar 03;18:617-629
pubmed: 29845010
Brain. 2019 Aug 1;142(8):2466-2482
pubmed: 31199471
Neurology. 2013 Jul 23;81(4):337-45
pubmed: 23803320
J Alzheimers Dis. 2016 Jun 18;53(3):1033-42
pubmed: 27340847
Neurology. 2016 Apr 12;86(15):1393-1399
pubmed: 26992858
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16
pubmed: 19700669
Brain. 2018 Jan 1;141(1):302-317
pubmed: 29228180

Auteurs

Fatma Ozlem Hokelekli (FO)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Joseph R Duffy (JR)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Heather M Clark (HM)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Rene L Utianski (RL)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Hugo Botha (H)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Julie A Stierwalt (JA)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Edythe A Strand (EA)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Mary M Machulda (MM)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.

Jennifer L Whitwell (JL)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Keith A Josephs (KA)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH